| Marksans Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524404 |
NSE Symbol : MARKSANS |
P/E(TTM) : 36.46 |
|
ISIN Demat : INE750C01026 |
Div & Yield% : 0.41 |
EPS(TTM) : 5.32 |
|
Book Value(₹) : 32.99 |
Market Cap(₹Cr) : 8,789.11 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,174.37 | 853.27 | 655.20 | 658.29 | 599.55 |
| Other Income | 69.83 | 62.07 | 60.48 | 42.25 | 31.16 |
| Stock Adjustments | -0.70 | 7.25 | 10.19 | -3.89 | -0.55 |
| Total Income | 1,243.50 | 922.59 | 725.87 | 696.65 | 630.16 |
| EXPENDITURE : | |||||
| Raw Materials | 639.24 | 486.18 | 404.64 | 373.70 | 337.36 |
| Power and Fuel Cost | 30.73 | 26.04 | 14.24 | 11.49 | 10.90 |
| Other Manufacturing Expenses | 64.62 | 46.10 | 21.09 | 5.25 | 6.98 |
| Selling and Administration Expenses | 112.99 | 73.19 | 61.54 | 67.57 | 60.08 |
| Miscellaneous Expenses | 20.37 | 11.88 | 15.89 | 22.22 | 15.31 |
| Employee Benefit Expenses | 101.68 | 77.19 | 56.09 | 60.46 | 54.64 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 273.88 | 202.01 | 152.38 | 155.97 | 144.87 |
| Interest | 1.17 | 0.99 | 3.61 | 3.80 | 5.35 |
| Gross Profit | 272.71 | 201.02 | 148.77 | 152.17 | 139.52 |
| Depreciation | 29.45 | 29.13 | 16.74 | 17.66 | 15.19 |
| Profit Before Tax | 243.26 | 171.89 | 132.03 | 134.51 | 124.33 |
| Current Tax | 52.14 | 37.46 | 29.34 | 30.02 | 28.19 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.84 | 0.68 | -0.17 | 0.50 | -2.24 |
| Reported Net Profit | 188.27 | 133.76 | 102.87 | 103.99 | 98.38 |
| Extraordinary Items | 0.51 | 0.07 | -0.05 | 0.00 | 0.03 |
| Adjusted Net Profit | 187.76 | 133.69 | 102.92 | 103.99 | 98.35 |
| Adjustment below Net Profit | -0.30 | 0.28 | -8.64 | 0.05 | -0.20 |
| Profit/Loss Balance carried down | 345.00 | 233.61 | 155.21 | 61.41 | -32.69 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 27.19 | 22.66 | 15.82 | 10.23 | 4.09 |
| P & L Balance carried down | 505.78 | 345.00 | 233.61 | 155.21 | 61.41 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 80.00 | 60.00 | 50.00 | 25.00 | 25.00 |
| Dividend Per Share(Rs) | 0.80 | 0.60 | 0.50 | 0.25 | 0.25 |
| Earnings Per Share-Unit Curr | 4.15 | 2.95 | 2.27 | 2.54 | 2.40 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 30.53 | 26.98 | 24.52 | 16.90 | 14.65 |
| Book Value(Adj)-Unit Curr | 30.53 | 26.98 | 24.52 | 16.90 | 14.65 |
